700 patients110,866 observations180 daysLIVE

Patient P-02122

Synthetic patientMETA-24 · Day 136 · 65–74 · F · baseline S10Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
56%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S10
  2. Day 15 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • GI instability+28
  • Inflammatory activity+20
  • Nutritional resilience-20
  • Treatment adherence+3

What helped?

No interventions yet.

    LIFE OS recommendation
    Dietary Support Protocol NP-02
    41%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 50% showed improvement
    • median effect visible after 10 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    40 min
    worsening · -9.0 vs previous 14 d
    Sleep duration
    Wearable
    6.3 h
    stable · -0.2 vs previous 14 d
    Energy level
    Daily log
    5.2/10
    worsening · -0.8 vs previous 14 d
    Steps
    Wearable
    3,843
    worsening · -945 vs previous 14 d
    GI burden
    Companion
    36.7/100
    worsening · +15.9 vs previous 14 d
    Adherence
    Companion
    96.5 %
    stable · +0.7 vs previous 14 d
    Sleep quality
    Wearable
    46.7/100
    worsening · -7.7 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    143 mg/dL
    worsening · +7.6 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 45 from the failing basin, 45 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    • More protein
      GI -4.8 next day on high-intake days · n 20
    Would not help
    • BR-03 Behavioural Recommendation
      only 25% improved among 8 similar
    • Keep simple carbs low
      GI +4.9 next day on high-intake days · n 20
    • Keep fat low
      GI +4.4 next day on high-intake days · n 21
    • Keep ultra-processed low
      GI +3 next day on high-intake days · n 18
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Simple carbohydrates
      +4.9detractor · 95%
    • Protein
      -4.8supporter · 95%
    • Dietary fat load
      +4.4detractor · 95%
    • Ultra-processed food
      +3detractor · 72%
    • Histamine load
      -2no signal · 42%
    • Caffeine
      -1.7no signal · 38%
    • Alcohol
      +1.5no signal · 32%
    • Insoluble fibre
      -1.3no signal · 27%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 80
      • MicrobiomeButyrate capacity 30/100
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Inflammatory signalling 45
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 41
    • Autonomic recovery 40
      • Wearable3,843 steps/day
      • WearableShort sleep window
    • Mucosal barrier integrity 30
      • MicrobiomeAkkermansia low → thinner mucus layer
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 2.3 · butyrate capacity 30/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    61 ms
    Sleep
    6.8 h
    Steps
    3,760
    Resting HR
    69 bpm
    Daily log: GI score 37, nutritional resilience 50, adherence 97.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0248447%S15GI-04improved49
    P-0205244%S11HY-01no change48
    P-0227443%S15DT-01improved50
    P-0261643%S0651
    P-0247042%S1160
    P-0202341%S0746
    P-0204541%S0752
    P-0213041%S2049
    P-0231241%S2054
    P-0210740%S17GI-04no change49
    P-0247940%S13DT-01improved48
    P-0259940%S14HY-01improved54